Rylaze Injection
Product Images NDC 68727-900

2 FDA label images from Jazz Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rylaze (NDC 68727-900). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jazz Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label (Image 01)

Carton-label (Image 01)
Carton packaging label for Rylaze 10 mg/0.5 mL injection, containing asparaginase erwinia chrysanthemi (recombinant)-rywn. The label indicates intramuscular use, sterile single-dose vials (3 x 0.5 mL), and storage instructions at 2°C to 8°C. Distributed by Jazz Pharmaceuticals, Inc., with manufacturing in Denmark.*
FDA Label Image

Vial (Vial Label)

Vial (Vial Label)
Label for Rylaze 10 mg/0.5 mL injection, containing asparaginase erwinia chrysanthemi (recombinant)-rywn. The product is for intramuscular use and prescription only. Labeler is Jazz Pharmaceuticals, Inc. The label includes a barcode, lot number field, and expiration date field.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.